CITLALY HERNANDEZ: Open Payments
NPI 1568146371 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,876 in 100 payments from 13 companies in 2025. Trend: 2023 $418 · 2024 $2,064 · 2025 $1,876
Food & beverage: $1,876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $527 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $302 |
| Janssen Biotech, Inc. | 10 | $189 |
| PFIZER INC. | 19 | $186 |
| GENZYME CORPORATION | 6 | $162 |
| Regeneron Healthcare Solutions, Inc. | 6 | $158 |
| Aimmune Therapeutics, Inc. | 6 | $138 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Lilly USA, LLC | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $32 |
Products named: RINVOQ, DUPIXENT, ENTYVIO, TREMFYA, ZENPEP, XELJANZ, SKYRIZI, LINZESS.
Industry payments across NC — which companies pay providers there.
